Novo Nordisk taps Trialbee for online recruitment of trial patients

Novo Nordisk ($NVO) is working with Trialbee in a bid to clear the patient recruitment bottleneck by engaging with patient groups online. Trialbee informs people about upcoming trials by talking directly to patient groups on social media and through mobile apps. This should mean more patients hear about Novo's trials, increasing the likelihood of the company hitting its enrollment targets. News

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.